Shizuoka, Japan

Keita Aoshima

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Maruhachi Muramatsu, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keita Aoshima. Retrieved from https://idiyas.com/inventor/keita-aoshima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keita Aoshima: Advancing Animal-Free Cell Culture

Introduction

Keita Aoshima is an inventor based in Shizuoka, Japan, and works at Maruhachi Muramatsu, Inc. His patent work focuses on peptide-based approaches to cell culture and protein production.

Latest Patents

Aoshima is associated with one patent, titled “Peptide, Cell Growth Promoter, Protein Production Promoter, Culture Medium, Cell Growth Method Using Peptide, and Protein Production Method Using Peptide.” The invention addresses the development of synthetic culture media without animal-derived components. It describes media containing selected peptides that may promote cell growth or support protein production, including Gly-Glu-Lys (GEK), Asp-Gly-Pro (DGP), Ala-Gly-Lys (AGK), Gly-Pro-Pro (GPP), Gly-Gly-Pro (GGP), Ala-Glu-Lys (AEK), Ala-Gly-Gly (AGG), Ala-Ser-Asn (ASN), and Glu-Gly-Lys (EGK).

Career Highlights

Aoshima’s listed patent reflects work on alternatives to animal-derived culture ingredients. The disclosed peptides are intended for use in culture media and related methods for growing cells and producing proteins.

Collaborations

Aoshima’s listed coworkers include Yoshinori Hokari and Natsuko Narawa. His work is associated with Maruhachi Muramatsu, Inc.

Conclusion

Keita Aoshima’s patent centers on peptide-containing, animal-free culture media designed to support cell growth and protein production.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…